A revolution in weight loss treatment may force a reckoning for food and beverage companies

  • 📰 CNBC
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

Business News News

Business Business Latest News,Business Business Headlines

Morgan Stanley said a sizeable demographic representing a disproportionate share of food consumption will be changing their habits due to weight loss drugs.

If you have heard that new weight loss medications mean you can eat all the junk food you want and still lose weight — you've heard wrong. Still, it's undeniable that a huge shift is underway in how obesity and overweight is being treated by doctors due to a new class of drugs known as GLP-1 agonists. The drugs are more successful in achieving weight loss and appear to have fewer side effects than previous generations of obesity treatments.

Currently, it expects 40 million people have health insurance plans that would cover the medication. "Manufacturer supply constraints and the evolution of insurance coverage will likely impact broad [anti-obesity medication] accessibility, and this is a key question around use of these mediations," the analysts said. "It is unclear how insurance coverage will expand over time; it may depend on comorbidity trials .

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Morgan Stanley says buy 'top’ stocks like Apple to fight the growing market malaiseMorgan Stanley said it likes stocks like Apple as market uncertainty mounts.
Source: CNBC - 🏆 12. / 72 Read more »